Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-10.54%
↑ 68% above average
Average (9y)
-33.22%
Historical baseline
Range
High:-4.16%
Low:-125.55%
CAGR
+10.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -10.54% | +90.3% |
| 2023 | -108.64% | -1536.9% |
| 2022 | -6.64% | -4.4% |
| 2021 | -6.36% | +55.2% |
| 2020 | -14.20% | +88.7% |
| 2019 | -125.55% | -198.9% |
| 2018 | -42.01% | -420.8% |
| 2017 | -8.07% | -34.6% |
| 2016 | -5.99% | -44.0% |
| 2015 | -4.16% | - |